AST Continues Its Commitment to U.S. Drug Product Manufacturing with Placement of Isolated Fill-Finish System with Bora Pharmaceuticals
The globally recognized CDMO selects an isolated GENiSYS® C to be placed in its Baltimore, Maryland, aseptic fill-finish facility. TACOMA Wash., May 29, 2025 —AST, a leading provider of flexible drug product manufacturing solutions, has announced the placement of its advanced isolated GENiSYS C fill-finish system with Bora Pharmaceuticals, a premier international contract development and manufacturing organization (CDMO). […]
AST Celebrates 60 Years of Excellence in Innovation and Looks to the Future of Drug Product Manufacturing
This milestone celebration sets the stage for AST’s next phase of strategic growth, anchored by its revitalized Mission, Vision, and Purpose statements TACOMA Wash., April 30, 2025 — AST marked the launch of its 60th anniversary year at INTERPHEX 2025, using the prestigious industry event as a springboard to highlight six decades of innovation. Building […]